BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22645315)

  • 1. Phosphatidylinositol-3-kinase C2β and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells.
    Srivastava S; Cai X; Li Z; Sun Y; Skolnik EY
    Mol Cell Biol; 2012 Aug; 32(15):3132-9. PubMed ID: 22645315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β.
    Cai X; Srivastava S; Sun Y; Li Z; Wu H; Zuvela-Jelaska L; Li J; Salamon RS; Backer JM; Skolnik EY
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20072-7. PubMed ID: 22128329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease.
    Srivastava S; Li Z; Skolnik EY
    PLoS One; 2017; 12(8):e0183474. PubMed ID: 28820911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWAP-70 regulates mast cell FcepsilonRI-mediated signaling and anaphylaxis.
    Sivalenka RR; Sinha M; Jessberger R
    Eur J Immunol; 2008 Mar; 38(3):841-54. PubMed ID: 18236401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
    Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
    Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of acid sphingomyelinase in the regulation of mast cell function.
    Yang W; Schmid E; Nurbaeva MK; Szteyn K; Leibrock C; Yan J; Schaller M; Gulbins E; Shumilina E; Lang F
    Clin Exp Allergy; 2014 Jan; 44(1):79-90. PubMed ID: 24164338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blunted IgE-mediated activation of mast cells in mice lacking the Ca2+-activated K+ channel KCa3.1.
    Shumilina E; Lam RS; Wölbing F; Matzner N; Zemtsova IM; Sobiesiak M; Mahmud H; Sausbier U; Biedermann T; Ruth P; Sausbier M; Lang F
    J Immunol; 2008 Jun; 180(12):8040-7. PubMed ID: 18523267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine kinase 1 is pivotal for Fc epsilon RI-mediated mast cell signaling and functional responses in vitro and in vivo.
    Pushparaj PN; Manikandan J; Tay HK; H'ng SC; Kumar SD; Pfeilschifter J; Huwiler A; Melendez AJ
    J Immunol; 2009 Jul; 183(1):221-7. PubMed ID: 19542433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methoxychlor enhances degranulation of murine mast cells by regulating FcεRI-mediated signal transduction.
    Yasunaga S; Nishi K; Nishimoto S; Sugahara T
    J Immunotoxicol; 2015; 12(3):283-9. PubMed ID: 25418051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy.
    Collmann E; Bohnacker T; Marone R; Dawson J; Rehberg M; Stringer R; Krombach F; Burkhart C; Hirsch E; Hollingworth GJ; Thomas M; Wymann MP
    J Allergy Clin Immunol; 2013 Oct; 132(4):959-68. PubMed ID: 23683463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Src family kinase Fgr is critical for activation of mast cells and IgE-mediated anaphylaxis in mice.
    Lee JH; Kim JW; Kim DK; Kim HS; Park HJ; Park DK; Kim AR; Kim B; Beaven MA; Park KL; Kim YM; Choi WS
    J Immunol; 2011 Aug; 187(4):1807-15. PubMed ID: 21746961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses.
    Samayawardhena LA; Pallen CJ
    J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells.
    Srivastava S; Di L; Zhdanova O; Li Z; Vardhana S; Wan Q; Yan Y; Varma R; Backer J; Wulff H; Dustin ML; Skolnik EY
    Mol Biol Cell; 2009 Sep; 20(17):3783-91. PubMed ID: 19587117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leaves and pseudostems extract of Curcuma longa attenuates immunoglobulin E/bovine serum albumin-stimulated bone marrow-derived cultured mast cell activation and passive cutaneous anaphylaxis in BALB/c mice.
    Jayasinghe AMK; Kirindage KGIS; Kim SH; Lee S; Kim KN; Kim EA; Heo SJ; Ahn G
    J Ethnopharmacol; 2024 Mar; 321():117529. PubMed ID: 38042384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling.
    Kim MJ; Je IG; Song J; Fei X; Lee S; Yang H; Kang W; Jang YH; Seo SY; Kim SH
    Front Immunol; 2020; 11():50. PubMed ID: 32063904
    [No Abstract]   [Full Text] [Related]  

  • 17. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf kinase inhibitor protein negatively regulates FcεRI-mediated mast cell activation and allergic response.
    Lin W; Su F; Gautam R; Wang N; Zhang Y; Wang X
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9859-E9868. PubMed ID: 30282734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation.
    Wong MX; Roberts D; Bartley PA; Jackson DE
    J Immunol; 2002 Jun; 168(12):6455-62. PubMed ID: 12055265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orphan nuclear receptor NR4A1 promotes FcεRI-stimulated mast cell activation and anaphylaxis by counteracting the inhibitory LKB1/AMPK axis.
    Jin F; Li X; Deng Y; Timilshina M; Huang B; Kim DY; Chang JH; Ichinose H; Baek SH; Murakami M; Lee YJ; Chang HW
    Allergy; 2019 Jun; 74(6):1145-1156. PubMed ID: 30565708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.